Cristina Gavina1, Inês Falcão-Pires2, Paulo Pinho3, Maria-Conceição Manso4, Alexandra Gonçalves5, Francisco Rocha-Gonçalves5, Adelino Leite-Moreira6. 1. Department of Medicine, Faculty of Medicine, University of Porto, Porto, Portugal cristina.gavina@gmail.com. 2. Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto, Porto, Portugal. 3. Department of Cardiothoracic Surgery, Centro Hospitalar São João, Porto, Portugal. 4. Department of Biostatistics, Faculty of Health Sciences, University Fernando Pessoa - CIAGEB-UFP, Porto, Portugal REQUIMTE, University of Porto, Porto, Portugal. 5. Department of Medicine, Faculty of Medicine, University of Porto, Porto, Portugal. 6. Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto, Porto, Portugal Department of Cardiothoracic Surgery, Centro Hospitalar São João, Porto, Portugal.
Abstract
OBJECTIVES: Persistent left ventricular (LV) hypertrophy after surgery is frequent, but its clinical relevance is controversial. We evaluated if residual LV hypertrophy (LVH) is associated with clinical outcomes after aortic valve replacement (AVR) for severe aortic stenosis (AS). METHODS: We analysed clinical and echocardiographic parameters before and after AVR, in a prospective cohort of 132 patients with severe AS. The mean follow-up was 6.0 ± 1.5 years. Clinical endpoints were all-cause death and combination of as in all-cause death and non-fatal cardiovascular hospitalization. At AVR, myocardial biopsies for collagen volume fraction (CVF) evaluation were done in 56 random patients. RESULTS: Residual LVH was present in 44% of patients after AVR. Patients with residual LVH were older, more frequently women and had hypertension (HT). Preoperatively, they had higher LV mass indices (LVMI), higher E/e' and left atrial volume indices, as well as lower peak systolic annular velocity. Female gender, HT, LVMI and E/e' were independent predictors of persistent LVH. CVF at the time of surgery was higher in those with residual LVH (20.0 ± 14.6 vs 13.2 ± 11.5%, P = 0.027). The risk of all-cause death and non-fatal cardiovascular hospitalization was higher in patients with residual LVH [OR 2.89 (95% CI 1.12-7.44); P = 0.035], but there were no differences in all-cause mortality. Residual LVH was associated with a worse outcome in women but not in men. CONCLUSIONS: Residual LVH after AVR is common and is associated with worse prognosis, particularly in women. In addition, HT, higher baseline LVM and worse diastolic dysfunction can help to identify patients at risk for incomplete normalization of LVM.
OBJECTIVES: Persistent left ventricular (LV) hypertrophy after surgery is frequent, but its clinical relevance is controversial. We evaluated if residual LV hypertrophy (LVH) is associated with clinical outcomes after aortic valve replacement (AVR) for severe aortic stenosis (AS). METHODS: We analysed clinical and echocardiographic parameters before and after AVR, in a prospective cohort of 132 patients with severe AS. The mean follow-up was 6.0 ± 1.5 years. Clinical endpoints were all-cause death and combination of as in all-cause death and non-fatal cardiovascular hospitalization. At AVR, myocardial biopsies for collagen volume fraction (CVF) evaluation were done in 56 random patients. RESULTS: Residual LVH was present in 44% of patients after AVR. Patients with residual LVH were older, more frequently women and had hypertension (HT). Preoperatively, they had higher LV mass indices (LVMI), higher E/e' and left atrial volume indices, as well as lower peak systolic annular velocity. Female gender, HT, LVMI and E/e' were independent predictors of persistent LVH. CVF at the time of surgery was higher in those with residual LVH (20.0 ± 14.6 vs 13.2 ± 11.5%, P = 0.027). The risk of all-cause death and non-fatal cardiovascular hospitalization was higher in patients with residual LVH [OR 2.89 (95% CI 1.12-7.44); P = 0.035], but there were no differences in all-cause mortality. Residual LVH was associated with a worse outcome in women but not in men. CONCLUSIONS: Residual LVH after AVR is common and is associated with worse prognosis, particularly in women. In addition, HT, higher baseline LVM and worse diastolic dysfunction can help to identify patients at risk for incomplete normalization of LVM.
Authors: Anish N Bhuva; Thomas A Treibel; Antonio De Marvao; Carlo Biffi; Timothy J W Dawes; Georgia Doumou; Wenjia Bai; Kush Patel; Redha Boubertakh; Daniel Rueckert; Declan P O'Regan; Alun D Hughes; James C Moon; Charlotte H Manisty Journal: Eur Heart J Cardiovasc Imaging Date: 2020-04-01 Impact factor: 6.875
Authors: Mohammad Abdelghani; Rafael Cavalcante; Yosuke Miyazaki; Robbert J de Winter; Rogério Sarmento-Leite; José A Mangione; Alexandre Abizaid; Pedro A Lemos; Patrick W Serruys; Fabio S de Brito Journal: Clin Res Cardiol Date: 2017-04-25 Impact factor: 5.460
Authors: Raquel García; Ana B Salido-Medina; Aritz Gil; David Merino; Jenny Gómez; Ana V Villar; Francisco González-Vílchez; María A Hurlé; J Francisco Nistal Journal: Cells Date: 2020-03-30 Impact factor: 6.600